RBC Capital Maintains Outperform on Astera Labs, Lowers Price Target to $400
Benzinga Newsdesk 5 days ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Srini Pajjuri maintains Astera Labs (NASDAQ:ALAB) with a Outperform and lowers the price target from $500 to $400.
RBC Capital analyst Srini Pajjuri maintains Astera Labs (NASDAQ:ALAB) with a Outperform and lowers the price target from $500 to $400.